Daily Stock Analysis, OBE, OASMIA PHARMACEUTICAL AB - AMERICAN DEPOSITARY SHARES, priceseries

OASMIA PHARMACEUTICAL AB - AMERICAN DEPOSITARY SHARES. Daily Stock Analysis
Stock Information
Open
0.18
Close
0.16
High
0.18
Low
0.16
Previous Close
0.17
Daily Price Gain
-0.00
YTD High
141.81
YTD High Date
Feb 28, 2011
YTD Low
0.15
YTD Low Date
Mar 19, 2020
YTD Price Change
-66.85
YTD Gain
-99.76%
52 Week High
141.81
52 Week High Date
Feb 28, 2011
52 Week Low
0.15
52 Week Low Date
Mar 19, 2020
52 Week Price Change
-66.85
52 Week Gain
-99.76%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 30. 2017
7.28
Nov 14. 2017
7.97
11 Trading Days
9.49%
Link
LONG
Mar 29. 2018
6.85
Apr 24. 2018
7.80
17 Trading Days
13.84%
Link
LONG
Dec 31. 2018
2.82
Jan 17. 2019
3.38
12 Trading Days
19.98%
Link
LONG
Apr 16. 2019
2.11
Apr 26. 2019
2.26
7 Trading Days
7.37%
Link
Company Information
Stock Symbol
OBE
Exchange
NASDAQ
Company URL
http://www.oasmia.com
Company Phone
011 46 18 50 54 40
CEO
Mikael Asp
Headquarters
-
Business Address
VALLONGATAN 1, UPPSALA, SWEDEN 752 28
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001607245
About

Oasmia Pharmaceutical AB is engaged in reaserch and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Its portfolio includes Paclical, Doxophos, Docecal, and OAS-19 for human health; and Paccal Vet and Doxophos Vet for animal health. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Description

Developing formulations of widely-used cancer drugs for humans and dogs.